Economic and survival burden of dysphagia among inpatients in the United States.

The inpatient burden of dysphagia has primarily been evaluated in patients with stroke. It is unclear whether dysphagia, irrespective of cause, is associated with worse clinical outcomes and higher costs compared to inpatients with similar demographic, hospital, and clinical characteristics without dysphagia. The aim of this study is to assess how a dysphagia diagnosis affects length of hospital stay (LOS), costs, discharge disposition, and in-hospital mortality among adult US inpatients. Annual and overall dysphagia prevalence, LOS, hospital charges, inpatient care costs, discharge disposition, and in-hospital mortality were measured using the AHRQ Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample (2009-2013). Patients aged 45 years or older with ≤180 days of stay in hospital with and without dysphagia were included. Multivariable survey regression methods with propensity weighting were used to assess associations between dysphagia and different outcomes. Overall, 2.7 of 88 million (3.0%) adult US inpatients had a dysphagia diagnosis (50.2% male, 72.4% white, 74.6% age 65-90 years) and prevalence increased from 408,035 (2.5% of admissions) in 2009 to 656,655 (3.3%) in 2013. After inverse probability of treatment weighting adjustment, mean hospital LOS in patients with dysphagia was 8.8 days (95% CI 8.66-8.90) compared to 5.0 days (95% CI 4.97-5.05) in the non-dysphagia group (P < 0.001). Total inpatient costs were a mean $6,243 higher among those with dysphagia diagnoses ($19,244 vs. 13,001, P < 0.001). Patients with dysphagia were 33.2% more likely to be transferred to post-acute care facility (71.9% vs. 38.7%, P < 0.001) with an adjusted OR of 2.8 (95% CI 2.73-2.81, P < 0.001). Compared to non-cases, adult patients with dysphagia were 1.7 times more likely to die in the hospital (95% CI 1.67-1.74). Dysphagia affects 3.0% of all adult US inpatients (aged 45-90 years) and is associated with a significantly longer hospital length of stay, higher inpatient costs, a higher likelihood of discharge to post-acute care facility, and inpatient mortality when compared to those with similar patient, hospital size, and clinical characteristics without dysphagia. Dysphagia has a substantial health and cost burden on the US healthcare system.

Case reports: molar distalization with static repelling magnets. Part II.

The following two nonextraction therapy case reports demonstrate four important points: (1) Static repelling magnets, with certain characteristic parameters, distalize molars rapidly without adverse effects that are clinically discernable. Beneficial properties such as considerably reduced patient compliance requirements for force application, reduced mobility and discomfort, and mostly bodily movement are demonstrated clinically. (2) Anchorage can be controlled by using conventional techniques of anchorage augmentation or force reduction. (3) Treatment can be satisfactorily completed and documented in accord with contemporary criteria, with conventional therapeutic methods, once the initial, most difficult, magnetic molar distalization is completed. (4) The mechanism of action that accounts for the bioeffects remains unclear. However, we hypothesize that observed reduction of mobility and discomfort during rapid movement, combined with basic research and other clinical data, are attributable to the simultaneous, synergistic property of the magnetic force field, which disrupts the local equilibrium and also the static magnetic bioeffect. Among others, one distinguishing and pertinent bioeffect may be an increased rate of osteogenesis and bone remodeling, which may be very dependent on correct dosage through a possible biologic window and the field geometry.

A possible mechanism of action of repelling, molar distalizing magnets. Part I.

The magnetic component of certain time-varying inductive electromagnetic fields may be a large contributor to the accelerated osteogenic rate in nonunion fracture repair. Evidence is also accumulating to demonstrate that certain static magnetic fields may stimulate osteogenesis in in vitro and in vivo research, as well as orthopedic clinical application. We, therefore, hypothesize that static magnetic fields in orthodontics generate simultaneous force fields and bioeffects that may account for the observed benefits.

[Investigations of polymethylmetacrylate for replacement of small joints (author's transl)]. / Materialtechnische Untersuchung zur der Verwendbarkeit von Polymethylmethacrylat für den Erstz kleiner Gelenke

Swelling, monomer production, polymerization and frictional qualities of test samples of Palocos E, Palacos R and Paladon 65 (Messrs Kulzer & Co, Bad Homburg) have been examined in order to establish which of these plastic substances would be most suitable for replacement of small joints. We found that samples of Palacos E, hardened under pressure of 3.0 kp, had the most favorable qualities.